About EchoSens
EchoSens is a company based in Paris (France) founded in 2001 was acquired by Astorg Partners in March 2018. EchoSens has raised $32.75 million across 2 funding rounds from investors including Orbimed, European Union and Inner Mongolia Furui Medical Science. EchoSens operates in a competitive market with competitors including Mauna Kea Tech, CapsoVision, Smart Medical Systems, Invendo Medical and Fibronostics, among others.
- Headquarter Paris, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$32.75 M (USD)
in 2 rounds
-
Latest Funding Round
$100.97 K (USD), Grant
Jan 01, 2020
-
Investors
Orbimed
& 4 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of EchoSens
Unlock access to complete
Funding Insights of EchoSens
EchoSens has successfully raised a total of $32.75M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $100.97 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $100,972
-
First Round
First Round
(29 Apr 2015)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - EchoSens | Valuation |
investors |
|
| Apr, 2015 | Amount | Private Equity Round - EchoSens | Valuation | Orbimed , Cathay Capital |
|
Investors in EchoSens
EchoSens has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Orbimed, European Union and Inner Mongolia Furui Medical Science.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Cathay Capital is engaged in global investment and transformation.
|
Founded Year | Domain | Location | |
|
Astorg is engaged in private equity investment management.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EchoSens
Financial Statements - EchoSens
Echosens Comparisons
Competitors of EchoSens
EchoSens operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mauna Kea Tech, CapsoVision, Smart Medical Systems, Invendo Medical and Fibronostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Endomicroscopy devices are developed for gastrointestinal and respiratory endoscopy.
|
|
| domain | founded_year | HQ Location |
GI capsule endoscopy systems are developed for intestinal imaging.
|
|
| domain | founded_year | HQ Location |
Endoscopes and devices for GI diagnosis and treatment are produced.
|
|
| domain | founded_year | HQ Location |
Sterile single-use robotics-based endoscopes are developed for gastroenterology.
|
|
| domain | founded_year | HQ Location |
Non-invasive algorithm-based diagnostics
|
Frequently Asked Questions about EchoSens
EchoSens was founded in 2001 and raised its 1st funding round 14 years after it was founded.
EchoSens is headquartered in Paris, France.
EchoSens is a funded company, having raised a total of $32.75M across 2 funding rounds to date. The company's 1st funding round was a Private Equity Round of $32.75M, raised on Apr 29, 2015.
EchoSens was established in 2001 in Paris, France, within the medical diagnostics sector. Non-invasive products for detecting liver conditions, including fibrosis and steatosis, are developed and offered. FibroScan technology is employed to assess liver health without invasive procedures. Operations center on advancing diagnostic tools for healthcare providers across Europe and beyond, with a focus on liver disease evaluation.
EchoSens's top competitors include CapsoVision, Mauna Kea Tech and Inner Mongolia Furui Medical Science.
EchoSens has 5 investors. Key investors include Orbimed, European Union, Inner Mongolia Furui Medical Science, Cathay Capital, and Astorg.